1. Home
  2. Azioni
  3. Giappone
  4. Japan Exchange
  5. Takeda Pharmaceutical Company Limited
  6. SocietÓ
    4502   JP3463000004

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Rapporto
Tempo differito Japan Exchange  -  08:00 10/08/2022
3782.00 JPY   +0.91%
01/08JEFFERIES & CO. CAMBIA OPINIONE SU TAKEDA PHARMACEUTICAL COMPANY LIMITED: non è più Buy
MM
29/07L'utile attribuibile di Takeda Pharmaceutical nel primo trimestre fiscale è sceso del 24%.
MT
28/07Takeda registra un aumento dell'utile core del primo trimestre fiscale e del fatturato
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietÓFinanzaConsensusRevisioniDerivati 
AttivitÓ
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited Ŕ specializzata nello sviluppo, produzione e commercializzazione di prodotti farmaceutici soprattutto per le malattie metaboliche e cardiovascolari, i tumori e i disturbi del sistema nervoso centrale. L'attivitÓ Ŕ organizzata intorno a 2 aree:
- vendita di farmaci e prodotti di consumo;
- servizi.
Le vendite nette sono distribuite geograficamente come segue: Giappone (17,5%), Asia (5%), Stati Uniti (49%), Europa e Canada (20,8%), America Latina (3,8%), Russia e CIS (1,8%) e altro (2,1%).

Numero di dipendenti : 47 347 persone.
Vendite per attivitÓ
20212022Delta
Gastroenterology777 800.0024.3%875 685.0024.5% +12.58%
Other574 068.0018%624 150.0017.5% +8.72%
Plasma-derived Therapies Immunology420 389.0013.1%506 951.0014.2% +20.59%
Neuroscience417 297.0013%482 294.0013.5% +15.58%
Oncology416 512.0013%468 730.0013.1% +12.54%
Rare Hematology289 799.009.1%283 689.007.9% -2.11%
Rare Metabolic162 620.005.1%172 595.004.8% +6.13%
Hereditary Angioedema139 327.004.4%153 587.004.3% +10.23%
Rare Disease - Others--1 325.00--
JPY in Milioni
Vendite per regione
20212022Delta
United States1 567 930.0049%1 714 420.0048% +9.34%
Europe and Canada666 177.0020.8%739 168.0020.7% +10.96%
Japan559 748.0017.5%658 983.0018.5% +17.73%
Asia156 240.004.9%196 964.005.5% +26.07%
Latin America121 638.003.8%128 467.003.6% +5.61%
Other68 518.002.1%68 945.001.9% +0.62%
Russia / Commonwealth of Independent States57 560.001.8%62 057.001.7% +7.81%
JPY in Milioni
Dirigenti
Nome Titolo EtÓ Da
Christophe Weber Chief Operating & Corporate Officer 55 2014
Constantine Saroukos Chief Financial Officer & Director 51 2019
Andrew Plump Director, Research & Development President 56 2019
Michael Mendelsohn Chief Medical & Scientific Officer 66 2015
Norimasa Takeda Chief Accounting Officer & Corporate Controller - -
Christopher David O'Reilly Global Head-Investor Relations - 2011
Satoru Takemoto General Manager-Sales - -
Masato Iwasaki, Dr. Manager-Product Strategy 63 2008
Mwana Lugogo Chief Ethics Officer - -
Giles Platford President-Europe & Canada - 2017
Amministratori
Nome Titolo EtÓ Da
Masahiro Sakane Independent Outside Director 81 2014
Shiro Kuniya Auditor 65 2013
Yoshiaki Fujimori Independent Director 70 2016
Emiko Higashi Independent Outside Director 62 2016
Michel Orsinger Independent Outside Director 64 2016
Toshiyuki Shiga Independent Outside Director 68 2016
Jean-Luc Butel Independent Outside Director 65 2016
Koji Hatsukawa Independent Outside Director 70 2016
Olivier Bohuon Independent Non-Executive Director 63 2019
Ian T. Clark Independent Director 60 2019
Azioni
Voto QuantitÓFlottanteAutocontrolloFlottante totale
Azione A 0.01 1 582 263 225 1 530 916 939 96.8% 36 163 177 2.3% 96.8%
Azionisti
NomeAzioni%
Nomura Asset Management Co., Ltd. 68 143 099 4,31%
BlackRock Fund Advisors 51 074 730 3,23%
The Vanguard Group, Inc. 39 182 376 2,48%
Daiwa Asset Management Co. Ltd. 32 041 599 2,03%
Nippon Life Insurance Co. 31 824 000 2,01%
Nikko Asset Management Co., Ltd. 30 673 598 1,94%
Norges Bank Investment Management 23 314 335 1,47%
BlackRock Japan Co., Ltd. 23 218 800 1,47%
Takeda Pharmaceutical Company Limited 21 416 102 1,35%
Takeda Science Foundation 17 912 000 1,13%
Partecipazioni
NomeAzioni%Valorizzazione
DENALI THERAPEUTICS INC. (DNLI) 4 214 559 3,43% 124 034 471 USD
DAY ONE BIOPHARMACEUTICALS, INC. (DAWN) 6 012 758 8,36% 107 628 368 USD
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. (4886) 2 204 840 7,21% 16 310 502 USD
OVID THERAPEUTICS INC. (OVID) 7 531 996 10,7% 16 193 791 USD
MIRUM PHARMACEUTICALS, INC. (MIRM) 530 562 1,67% 10 324 737 USD
HILLEVAX, INC. (HLVX) 840 500 2,51% 9 186 665 USD
WAVE LIFE SCIENCES LTD. (WVE) 1 096 892 1,26% 3 564 899 USD
HOOKIPA PHARMA INC. (HOOK) 1 333 588 2,62% 2 173 748 USD
MOLECULAR TEMPLATES, INC. (MTEM) 2 314 659 4,11% 2 110 969 USD
OVID THERAPEUTICS, INC. 1 250 16,1% 2 688 USD
Mercati e indici
- Prime
- Nikkei 225 / Stoxx Asia Pacific 50, Stoxx Global 200
Codici di Borsa
- Codice Bloomberg :  4502:JP
- Codice Reuters :  4502.T
- Codice Datastream :  
Coordinate societÓ
Takeda Pharmaceutical Company Limited
1-1 Doshomachi 4-chome
JP-540-8645 Nishi-ku, Osaka

Telefono : +81 6 6204 2111
Fax : +81 6 6204 2880
Internet : http://www.takeda.co.jp
Portafoglio di marchi
In collaborazione conAllbrands.markets
Pi¨ marchi di Takeda Pharmaceutical Company Limited
Settore Prodotti farmaceutici - Altri
Var. 1genCapi. (M$)
TAKEDA PHARMACEUTICAL COMPANY LIMITED19.48%42 938
JOHNSON & JOHNSON-0.52%447 434
ELI LILLY AND COMPANY9.70%287 922
PFIZER, INC.-16.05%279 310
ROCHE HOLDING AG-16.02%275 991
ABBVIE INC.3.58%247 976
NOVO NORDISK A/S4.27%238 658
MERCK & CO., INC.16.81%226 779
ASTRAZENECA PLC24.94%203 058
NOVARTIS AG3.71%190 668
BRISTOL-MYERS SQUIBB COMPANY18.36%160 059
AMGEN INC.10.40%132 855
SANOFI7.79%122 268
GSK PLC0.20%80 582
BAYER AG10.98%52 412
DAIICHI SANKYO CO., LTD.23.11%51 146
CHUGAI PHARMACEUTICAL CO., LTD1.29%46 111
JIANGSU HENGRUI MEDICINE CO., LTD.-26.39%35 264
ASTELLAS PHARMA INC.9.25%27 665
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-32.20%26 482
CATALENT, INC.-15.54%19 378